MRE (medco research) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MRE (medco research)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (107)	7/13/1998 9:20:00 PM
From: Xiaoping Zhang	of 192

Thank you, Cacaito, for your information. What is your estimate of Q2? Mine is $ 0.36, not 0.41 or 0.44 as posted on the Yahoo massage board or by an analyst following this stock. My estimate is based on the past four consecutive Qs' revenue growth of 10% and enough deferred tax assets for Q2 and part of Q3. It is not a small feat for a microcap pharmaceutical co. like MRE to maintain a positive cash flow without resorting to debt or to issuing new shares. I consider 0.36 is a very good number. Anyone, comparing the financial strength of MRE to its fellow co.s in the same group, will appreciate it. X.Z. 7/13

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next